Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
This study enrolls adults who have certain neurological disorders and also healthy volunteers. The purpose of this study is to learn about the effects of COVID-19 in patients with certain autoimmune disorders, including MS, migraine and myasthenia gravis. Read More
Adults ages 18+
Are a patient of certain UBMD Neurology providers
This study enrolls people who are hospitalized with acute heart failure. The purpose of this study is to learn if it is safe and effective to start the study medication (empagliflozin) while a person is in the hospital for acute heart failure. Read More
-Adults ages 18+
-Currently hospitalized with primary diagnosis of acute heart failure
-Evidence of left ventricular ejection fraction, either reduced or preserved, in the 12 months
This study enrolls people who are HIV positive who are taking certain medication. If a person take Stribilid® or Genvoya®, there may be changes in the way their body uses or removes other medications. We want to study another approved treatment, Biktarvy®, that we believe is less likely to affect how the body handles other medications that a person is currently taking. This switch may improve quality of life. Read More
-Adults ages 18+.
-Positive for HIV.
-Taking current antiretroviral therapy GenvoyaTM or StribildTM for HIV-1 infection.
-Taking at least 1 or more other prescription medications.
This study is looking for women ages 18-24 who are in college. The purpose of this study is to get feedback about program designed for friends to help protect one another against sexual assault. Read More
Adult women ages 18-24.
Enrolled in a 4 year college or university
This study enrolls adults with peripheral arterial disease (PAD; blocked arteries in the legs) who are having a lower extremity endovascular intervention (EVI). The purpose of the study is to learn how well a blood test called Plateletcrit find blood clotting cells. We want to see if this test might be useful to learn about outcomes for this surgery. Read More
Adults ages 18+
Have undergone extremity endovascular intervention (EVI) treatment of lower extremity peripheral arterial disease (PAD) or critical limb ischemia
On aspirin at time of the intervention and will receive dual antiplatelet therapy after surgery with aspirin and clopidogrel for at least 30 days.
This study enrolls medical students, residents, and fellow physicians at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences who have a FitBit device. The purpose of this study is to learn what part of sleep health is associated with physician burnout to help decrease damage and improve sleep health. Read More
You are a medical student, resident, or fellow at University at Buffalo
Must have a FitBit device